You are viewing the site in preview mode

Skip to main content

Table 2 Pathological features

From: Clinicopathological characteristics and predictors of renal outcomes in diffuse crescentic glomerulonephritis : a retrospective single-center study from Western China

Characteristic

Type I(n = 12)

Type II(n = 70)

Type III(n = 25)

P value

Total(n = 70)

IgAN(n = 28)

LN(n = 27)

P value

Histological characteristics

 Number of glomeruli

11(9,14)

13(11,16)

12(10,14)

13(12,17)

0.131

12(9,15)

0.183

 Crescents(%)

71(57,83)

62.5(54.5,72.9)

63(55,69)

66.7(54.5,75.0)

0.523

66.7(51.7,75.0)

0.153

 Cellular crescents(%)

17(10,49)

26.1(11.6,50.0)

22(13,36)

37.5(7.7,52.4)

0.340

15.8(0.0,29.7)

0.028c

 Fibrocellular crescent(%)

28.15 ± 15.09

25.07 ± 15.51

25.5 ± 16.1

25.8 ± 15.7

0.792

29.61 ± 10.60

0.373

 Fibrous crescents(%)

13(0,26)

0.0(0.0,18.75)

3.3(0,21.1)

0(0,11.1)

0.552

20.0(11.1,29.2)

0.004c

 Fibrinoid necrosis, n(%)

2(16.7)

17(24.3)

5(17.9)

8(29.6)

0.412

13(52)

0.019c

 Bowman’s capsule rupture, n%

8(66.7)

0

0

0

 

1(4)

<0.001a, b

 Global glomerulosclerosis(%)

10.8(1.4,30.6)

0(0,11.5)

3.1(0,12.5)

0(0,11.1)

0.200

13.3(0,21.6)

0.007c

Interstitial inflammation, n(%)

0.180

 

0.038a

 Absent

0(0)

2(2.9)

0

1(3.7)

 

0(0)

 

 <25%

4(33.3)

56(80)

22(78.6)

20(74.1)

 

18(72)

 

 25–50%

7(58.3)

11(15.7)

5(17.9)

6(22.2)

 

6(24)

 

 >50%

1(8.3)

1(1.4)

1(3.6)

0

 

1(4)

 

Interstitial fibrossis, n(%)

    

<0.001d

 

<0.001a, b,c

 Absent

1(8.3)

19(27.1)

2(7.1)

9(33.3)

 

0(0)

 

 <25%

7(58.3)

44(62.9)

21(75)

16(59.3)

 

19(76)

 

 ≥25%

4(33.3)

7(10)

5(17.9)

2(7.4)

 

6(24)

 

Immunofluorescence pattern, n(%)

 C3 Number of negative

1(8.3)

1(1.4)

0

0

0.041d

4(16.7)

<0.001a, c

 Number of 1+

6(50)

16(22.9)

6(21.4)

4(14.8)

 

11(45.8)

 

 Number ≥ 2+

5(41.7)

53(75.7)

22(78.6)

23(85.2)

 

9(37.5)

 

 IgA Number of negative

7(58.3)

4(5.7)

0

3(11.1)

0.004d

19(79.2)

<0.001a, c

 Number of 1+

3(25)

12(17.1)

0

8(29.6)

 

3(12.5)

 

 Number ≥ 2+

2(16.7)

54(77.1)

28(100)

16(59.3)

 

2(8.3)

 

 IgG Number of negative

4(33.3)

39(55.7)

25(89.3)

3(11.1)

<0.001d

17(70.8)

0.079

 Number of 1+

5(41.7)

21(30.0)

3(10.7)

17(63)

 

7(29.2)

 

 Number ≥ 2+

3(25)

10(14.3)

0

7(25.9)

 

0(0)

 

 IgM Number of negative

8(66.7)

15(21.4)

5(17.9)

2(7.4)

0.064

12(50)

0.006a, c

 Number of 1+

4(33.3)

38(54.3)

18(64.3)

16(59.3)

 

8(33.3)

 

 Number ≥ 2+

0(0)

17(24.3)

5(17.9)

9(33.3)

 

4(16.7)

 

 C1q Number of negative

11(91.7)

36(51.4)

23(82.1)

1(3.7)

<0.001d

18(72)

<0.001a, b,c

 Number of 1+

1(8.3)

15(21.4)

5(17.9)

7(25.9)

 

7(28)

 

 Number ≥ 2+

0(0)

19(27.1)

0(0)

19(70.4)

 

0(0)

 
  1. Note: Values for categorical variables are given as number(percentage); values for continuous variables, as mean ± standard deviation or median [interquartile range].
  2. Abbreviations: IgAN, IgA nephropathy; LN, lupus nephritis; IgAVN, IgA vasculitis nephritis.aP <0.05 between typesIand II; bP <0.05 between typesIand III; cP <0.05 between types II and III.dP <0.05 between IgAN and LN.